A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma

Leuk Lymphoma. 2005 Jun;46(6):945-7. doi: 10.1080/10428190500057684.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dexamethasone / administration & dosage*
  • Disease-Free Survival
  • Doxorubicin / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Stem Cell Transplantation
  • Time Factors
  • Treatment Outcome
  • Vincristine / administration & dosage*

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin